Chemotherapy and Targeted Therapy Strategies in Patients with Unresectable or Borderline Resectable Metastatic Colorectal Cancer: Evidence for a Lack of Focus on Resection Rates.
Jan ZmucJan HeilCaroline HerfarthWolf O BechsteinChristine KochJörg TrojanAndreas A SchnitzbauerPublished in: Annals of surgical oncology (2023)
The ORR and survival rates in unresectable and borderline resectable mCRC were improved by modern CTx and TT that did not translate into higher RR, mostly due to the lack of expert involvement.